FAQs
What are the earliest signs of familial dysautonomia in newborns?
Infants often present with feeding difficulties, low muscle tone (hypotonia), and a lack of tear production. These clues usually appear within the first few months of life.
How is familial dysautonomia diagnosed?
Diagnosis is confirmed by DNA testing for the IKBKAP gene mutation. A simple blood draw is sent to a genetic lab, and results typically return within a few weeks.
Can the symptoms be managed, and what treatments are most effective?
While there is no cure, supportive care—such as gastrostomy feeding, artificial tears, salt supplementation, compression garments, and physical therapy—greatly improves quality of life. Medications like midodrine or fludrocortisone help control blood‑pressure fluctuations.
What is the long‑term outlook for someone with familial dysautonomia?
Recent studies show a median life expectancy of 35‑40 years, thanks to better multidisciplinary care. Early intervention, regular monitoring, and adherence to treatment plans are key factors for a longer, healthier life.
Should family members be tested even if they show no symptoms?
Yes. Carrier testing is recommended for siblings, parents, and extended relatives, especially in families of Ashkenazi Jewish descent. Knowing carrier status aids family planning and early detection in future children.
